Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Cancer Treatment Reviews|September 25, 2016
Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapyEmiliano Calvo, Manuela Schmidinger, Daniel Y C Heng, et al.
Frontiers in Immunology|August 28, 2023
Considerations for the clinical development of immuno-oncology agents in cancerAtanasio Pandiella, Emiliano Calvo, Victor Moreno, et al.
Cancer Treatment Reviews|November 6, 2020
Comparison of radiological criteria for hyperprogressive disease in response to immunotherapyAna Luiza Gomes da Morais, Maria de Miguel, José Miguel Cardenas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
T-cell-engaging Therapy for Solid TumorsMaria de Miguel, Pablo Umana, Ana Luiza Gomes de Morais, et al.
CA: a Cancer Journal for Clinicians|November 20, 2013
New approach to cancer therapy based on a molecularly defined cancer classificationJavier Cortés, Emiliano Calvo, Ana Vivancos, et al.
Anticancer Research|July 4, 2012
Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinomaJames Larkin, Norbert Esser, Emiliano Calvo, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 21, 2013
Simultaneous online SPE-HPLC-MS/MS analysis of docetaxel, temsirolimus and sirolimus in whole blood and human plasmaAlicia Navarrete, M Paz Martínez-Alcázar, Ignacio Durán, et al.
Clinical Therapeutics|November 26, 2015
An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy FailedSteven Sherman, Billy Amzal, Emiliano Calvo, et al.
Cancer|June 20, 2020
Increased vulnerability of clinical research units during the COVID-19 crisis and their protectionMaria de Miguel, Bernard Doger, Valentina Boni, et al.
Investigational New Drugs|January 16, 2016
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignanciesEmiliano Calvo, Guru Reddy, Valentina Boni, et al.
Pageof 16